224 related articles for article (PubMed ID: 28450469)
1. Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-
Zou ZQ; Chen JJ; Feng HF; Cheng YF; Wang HT; Zhou ZZ; Guo HB; Zheng W; Xu JP
J Pharmacol Exp Ther; 2017 Jul; 362(1):67-77. PubMed ID: 28450469
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice: Involvement of p38 and JNK Signaling Pathways.
Yu H; Zou Z; Zhang X; Peng W; Chen C; Ye Y; Xu J; Wang H
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419799
[TBL] [Abstract][Full Text] [Related]
3. Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Zhao D; Kwon SH; Chun YS; Gu MY; Yang HO
Neurochem Res; 2017 Feb; 42(2):667-677. PubMed ID: 27933547
[TBL] [Abstract][Full Text] [Related]
4. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.
Guo H; Cheng Y; Wang C; Wu J; Zou Z; Niu B; Yu H; Wang H; Xu J
Neuropharmacology; 2017 Apr; 116():260-269. PubMed ID: 28065587
[TBL] [Abstract][Full Text] [Related]
5. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-γ signaling pathway.
Choi MJ; Lee EJ; Park JS; Kim SN; Park EM; Kim HS
Biochem Pharmacol; 2017 Nov; 144():120-131. PubMed ID: 28757373
[TBL] [Abstract][Full Text] [Related]
7. FCPR16, a novel phosphodiesterase 4 inhibitor, produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress.
Zhong Q; Yu H; Huang C; Zhong J; Wang H; Xu J; Cheng Y
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():62-75. PubMed ID: 30391306
[TBL] [Abstract][Full Text] [Related]
8. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
Li H; Li J; Zhang X; Feng C; Fan C; Yang X; Zhang R; Zhu F; Zhou Y; Xu Y; Liu H; Tang W
Biochem Pharmacol; 2020 Jul; 177():113958. PubMed ID: 32251674
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behaviors and Prevents Dendritic Spine Loss in Mice Hippocampi.
Yu H; Zhong J; Niu B; Zhong Q; Xiao J; Xie J; Lin M; Zhou Z; Xu J; Wang H
Int J Neuropsychopharmacol; 2019 Feb; 22(2):143-156. PubMed ID: 30407503
[TBL] [Abstract][Full Text] [Related]
10. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway.
Xu B; Wang T; Xiao J; Dong W; Wen HZ; Wang X; Qin Y; Cai N; Zhou Z; Xu J; Wang H
Biochem Pharmacol; 2019 May; 163():234-249. PubMed ID: 30797872
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine modulates the production of interleukin-6 and tumor necrosis factor-alpha via the cAMP/PKA/CREB signaling pathway in lipopolysaccharide-activated microglia.
Wang B; Chen T; Wang J; Jia Y; Ren H; Wu F; Hu M; Chen Y
Int Immunopharmacol; 2018 Mar; 56():168-178. PubMed ID: 29414647
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase 2 Inhibitor CAY10683 Alleviates Lipopolysaccharide Induced Neuroinflammation Through Attenuating TLR4/NF-κB Signaling Pathway.
Jiao FZ; Wang Y; Zhang HY; Zhang WB; Wang LW; Gong ZJ
Neurochem Res; 2018 Jun; 43(6):1161-1170. PubMed ID: 29675728
[TBL] [Abstract][Full Text] [Related]
13. PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-κB and CREB/CBP signaling pathways.
Kim MO; Lee YJ; Park JH; Ryu JM; Yun SP; Han HJ
Biochim Biophys Acta; 2012 Oct; 1820(10):1636-46. PubMed ID: 22658979
[TBL] [Abstract][Full Text] [Related]
14. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling.
Park T; Chen H; Kevala K; Lee JW; Kim HY
J Neuroinflammation; 2016 Nov; 13(1):284. PubMed ID: 27809877
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CREB and NF-kappaB signal transduction by cannabinol in activated thymocytes.
Herring AC; Faubert Kaplan BL; Kaminski NE
Cell Signal; 2001 Apr; 13(4):241-50. PubMed ID: 11306241
[TBL] [Abstract][Full Text] [Related]
16. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK.
Daniele S; Da Pozzo E; Zappelli E; Martini C
Cell Signal; 2015 Aug; 27(8):1609-29. PubMed ID: 25911310
[TBL] [Abstract][Full Text] [Related]
17. Histamine H3R antagonist counteracts the impaired hippocampal neurogenesis in Lipopolysaccharide-induced neuroinflammation.
Wang J; Liu B; Sun F; Xu Y; Luan H; Yang M; Wang C; Zhang T; Zhou Z; Yan H
Int Immunopharmacol; 2022 Sep; 110():109045. PubMed ID: 35978505
[TBL] [Abstract][Full Text] [Related]
18. Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway.
Li D; Xu J; Qin Y; Cai N; Cheng Y; Wang H
Int Immunopharmacol; 2021 Jan; 90():107176. PubMed ID: 33243606
[TBL] [Abstract][Full Text] [Related]
19. Penehyclidine hydrochloride inhibits the LPS-induced inflammatory response in microglia.
Huang C; He J; Chen Y; Zhang Y; Chen C
J Surg Res; 2014 May; 188(1):260-7. PubMed ID: 24439132
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression.
Jung JS; Shin JA; Park EM; Lee JE; Kang YS; Min SW; Kim DH; Hyun JW; Shin CY; Kim HS
J Neurochem; 2010 Dec; 115(6):1668-80. PubMed ID: 20969575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
